drugset
drugset / Trial / NCT04474262

Efficacy of Albumin Plus Midodrine v/s Albumin Alone in Reducing Incidence of Paracentesis Induced Circulatory Dysfunctions in ACLF Patients.

NCT04474262 ↗

Unknown 150 enrolled Institute of Liver and Biliary Sciences, India
RandomizedParallel-groupSingle-blindTreatment

Summary

The patients with ACLF having Ascites who require ascitic tapping will undergone ascitic tapeither under albumin cover alone or with midodrine. The patient will be monitored for complication and changes of PICD. Study analysis will be done with primary objective being reduction in incidence of PICD.

Timeline

Start
2020-07-15
Primary completion
2021-03-31
Completion
2021-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Midodrine Small molecule 7.5 mg Oral
Subject Midodrine Small molecule 10 mg Oral
Background Albumin Protein / enzyme biologic 8 mg/ml —

Indications

liver disorder